We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
-4.19%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$26.1B
AUM Growth
-$4.09B
Cap. Flow
-$2.77B
Cap. Flow %
-10.63%
Top 10 Hldgs %
22.95%
Holding
1,846
New
56
Increased
388
Reduced
1,301
Closed
96

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$366M
2
MSFT icon
Microsoft
MSFT
+$279M
3
AMZN icon
Amazon
AMZN
+$213M
4
TSLA icon
Tesla
TSLA
+$109M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.74%
2 Consumer Staples 11.79%
3 Consumer Discretionary 11.57%
4 Industrials 10.74%
5 Healthcare 10.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPIR icon
1726
Spire Global
SPIR
$425M
$15K ﹤0.01%
1,723
-33
-2% -$358
WGS icon
1727
GeneDx Holdings
WGS
$1.75B
$15K ﹤0.01%
528
-10
-2% -$458
VBIV
1728
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$15K ﹤0.01%
708
-14
-2% -$377
CLVS
1729
DELISTED
Clovis Oncology, Inc.
CLVS
$14K ﹤0.01%
12,153
+948
+8% +$1.48K
ADAP
1730
DELISTED
Adaptimmune Therapeutics
ADAP
$13K ﹤0.01%
12,085
+1,361
+13% +$2.5K
SLQT icon
1731
SelectQuote
SLQT
$114M
$13K ﹤0.01%
18,095
-510
-3% -$847
VSTM icon
1732
Verastem
VSTM
$532M
$13K ﹤0.01%
1,316
+106
+9% +$1.48K
ML
1733
DELISTED
MoneyLion Inc.
ML
$12K ﹤0.01%
458
-83
-15% -$3.81K
BINI
1734
DELISTED
Bollinger Innovations
BINI
0
BODI icon
1735
The Beachbody Company
BODI
$78.9M
$11K ﹤0.01%
231
-4
-2% -$254
LTCH
1736
DELISTED
Latch, Inc. Common Stock
LTCH
$11K ﹤0.01%
+11,980
New +$13.7K
ASTR
1737
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$10K ﹤0.01%
1,118
+40
+4% +$675
HYMC icon
1738
Hycroft Mining Holding Corp
HYMC
$1.85B
$9K ﹤0.01%
1,664
-32
-2% -$284
CARM
1739
DELISTED
Carisma Therapeutics
CARM
$7K ﹤0.01%
839
+62
+8% +$844
FFAI
1740
Faraday Future Intelligent Electric
FFAI
$15.8M
0
BRDS
1741
DELISTED
Bird Global, Inc.
BRDS
$7K ﹤0.01%
756
-14
-2% -$165
SPPI
1742
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$7K ﹤0.01%
15,826
+1,801
+13% +$1.77K
DOMA
1743
DELISTED
Doma Holdings, Inc.
DOMA
$7K ﹤0.01%
604
-11
-2% -$197
RKLY
1744
DELISTED
Rockley Photonics Holdings Limited
RKLY
$7K ﹤0.01%
11,237
-214
-2% -$365
AKBA icon
1745
Akebia Therapeutics
AKBA
$327M
$5K ﹤0.01%
15,465
+1,172
+8% +$460
BBLN
1746
DELISTED
Babylon Holdings Limited
BBLN
$5K ﹤0.01%
480
-9
-2% -$184
AUD
1747
DELISTED
Audacy, Inc.
AUD
$5K ﹤0.01%
13,290
-120
-0.9% -$72
ATNX
1748
DELISTED
Athenex, Inc. Common Stock
ATNX
$4K ﹤0.01%
+661
New +$6.79K
VTGN icon
1749
VistaGen Therapeutics
VTGN
$9.29M
$3K ﹤0.01%
715
-14
-2% -$139
AAT
1750
American Assets Trust
AAT
$1.49B
-7,058
Closed -$209K

Similar funds

ProShare Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, ProShare Advisors held 1,846 positions worth $26.1B, down 14% from $30.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

ProShare Advisors withdrew a net $2.77B in Q3 2022, closing 96 positions and reducing 1,301 holdings. Its most notable exit was Neenah, Inc. Common Stock, an estimated $7.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, ProShare Advisors opened a new position in Xometry worth $7.31M.

  • ProShare Advisors's largest Q3 2022 buy was Xometry: 128,758 shares worth $7.31M.
  • ProShare Advisors added most to Target in Q3 2022, an estimated $49.4M increase.
  • ProShare Advisors's biggest Q3 2022 reduction was Apple, cutting an estimated $366M.
  • ProShare Advisors fully exited Neenah, Inc. Common Stock in Q3 2022, selling an estimated $7.52M.
  • ProShare Advisors's ten largest holdings make up 23% of its $26.1B portfolio in Q3 2022.
  • ProShare Advisors opened 56 new positions and closed 96 in Q3 2022.
  • ProShare Advisors's portfolio value fell 14% quarter-over-quarter to $26.1B.

Based on ProShare Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.